23 October 2024
Read More3 October 2024
Read More26 September 2024
Read MoreWe are a family of strong 800+ people including 470+ professionals working from 14 locations across India.
We have a rich heritage and enduring legacy which are pivotal in shaping trust, excellence, and unparalleled legal expertise, thus building a strong reputation and a trusted brand.
Read MoreWe started in 1985 in a single room set up by the two founders with no prior experience of working in a law firm. Both the founders had outstanding academic records and focused on their deep understanding of the law to form the foundation of the firm.
Integrity, Knowledge and Passion are the principles that resonate with every member of our LKS family and the work that we do. These values drive us to build a community of legally sound professionals and well-serviced clients.
Everything we have accomplished over the last four decades is a result of our unique way of thinking which is deeply influenced by our core values and principles that define us.
Read MoreWe and our professionals consistently garner appreciation for the quality of our services and the depth of our legal expertise. This consistent acknowledgment serves as a testament to our unwavering commitment to exceed expectations.
The article in this issue of IPR Amicus explores the scope of patentability and infringement concerning product-by-process claims with a specific emphasis on the recent two decisions of the Delhi High Court. The authors note how the decision of the Division Bench of the Delhi High Court supports the requirements defined by Clause 7.9 of the “Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals” for product-by-process claims. Elaborately stating the facts of the case, the contentions of the parties, and the decision of the Single Bench, the authors note that the Division Bench has stayed the finding of the Single Bench while it did not agree with the views of the Single Bench that prima facie the patent involved in the dispute is a product-by-process claim and monopoly will be limited to the product obtained by the specific process in the claims. According to the authors, consequently, the patentability and infringement analysis for product-by-process claims should predominantly focus on the product feature stated in the claim.
The article in this issue of IPR Amicus, while exploring the subject, analyses various case...
The decision focused on two pivotal issues - whether the enhanced bioavailability data could be...
Get access to our latest newsletters, articles and events:
Scan the QR code to get in
touch with us